Krishnan Mahesh

Halozyme Therapeutics, Inc. · Director

Krishnan Mahesh is listed in public filings as director. This Krishnan Mahesh insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Halozyme Therapeutics, Inc. (HALO). Investors use Krishnan Mahesh's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Halozyme Therapeutics, Inc.HALO$548k7.3k sharesSellJun 29, 2026$75.00$68.65